TLDRocket
Sign in

Drug Discovery

56 summarised stories about Drug Discovery, each linking back to the original source. Browse all topics →

+ Follow this topic

Key players

OpenAI Anthropic Co-Scientist Co-Scientist Google DeepMind Isomorphic Labs

Saturday, 29 August 2026

Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmine

Fortune 41

Drugmakers and investors are pushing baldness drug candidates after new clinical results, sending Veradermics and Absci shares up sharply and lifting Cosmo on experimental male-hair-loss data. Cosmo plans to submit a new drug application to US regulators in the first quarter of 2027, with analysts expecting its stock could nearly double in the next 12 months. Investment focus shifts from GLP-1 obesity treatments toward cash-pay, out-of-pocket hair-loss medicines, with more companies and AI-designed candidates competing for approvals despite high development risk.

Read the full story
Business Funding AI & Healthcare Drug Discovery

The daily briefing

Every AI story that matters, in your inbox by 8am.

TLDRocket reads all relevant sources, removes duplicate coverage, and summarises the day in two minutes. Follow companies and topics for alerts, or get the briefing in Slack. Free, no spam, unsubscribe anytime.